Last reviewed · How we verify
NCT04201600
Glucose Variability and Cognition in Prediabetes
trial testing Continuous Glucose Monitoring System (CGMS) in Glucose Metabolism Disorders (Including Diabetes Mellitus) in 30 participants. Currently enrolling.
30 November 2026
Quick facts
| Lead sponsor | University of Maryland, Baltimore |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 March 2022 |
| Primary completion | 30 November 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Continuous Glucose Monitoring System (CGMS)
Conditions studied
- Glucose Metabolism Disorders (Including Diabetes Mellitus) — all drugs for Glucose Metabolism Disorders (Including Diabetes Mellitus) →
- Cognitive Decline — all drugs for Cognitive Decline →
- Functional Status — all drugs for Functional Status →
- PreDiabetes — all drugs for PreDiabetes →
Sponsor
University of Maryland, Baltimore
Who can join
50 and older, any sex, with Glucose Metabolism Disorders (Including Diabetes Mellitus) or Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04201600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glucose Metabolism Disorders (Including Diabetes Mellitus)
Currently open trials in the same condition.
- NCT06575426 — A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes M · Phase 1, PHASE2 · recruiting
- NCT06529965 — Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM · NA · recruiting
- NCT05764200 — Acute Microbial Switch · NA · recruiting
- NCT06334172 — The Role of Oxytocin in Regulating Blood Glucose · NA · recruiting
- NCT07172009 — The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals · NA · recruiting
Other University of Maryland, Baltimore trials
Trials by the same sponsor.
- NCT07537413 — Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia · Phase 4 · not yet recruiting
- NCT07221799 — OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis · Phase 1 · not yet recruiting
- NCT07094672 — Development of an Opioid Withdrawal Clinical Outcome Assessment · not yet recruiting
- NCT06583239 — Hub-Based Engagement Navigator Service to Reduce CSC Disengagement · NA · not yet recruiting
- NCT07536412 — Decision Aid Efficacy in Low Risk Thyroid Cancer · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04201600 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Maryland, Baltimore
- Last refreshed: 30 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04201600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing